2010
Cardiovascular registry research comes of age
McNamara RL. Cardiovascular registry research comes of age. Heart 2010, 96: 908. PMID: 20538664, DOI: 10.1136/hrt.2010.198069.Peer-Reviewed Original ResearchAcute Coronary SyndromeBiomedical ResearchCardiovascular DiseasesEvidence-Based MedicineHumansRegistries
2001
Evidence-based Practice Centers: Production of Evidence Report on Management of Atrial Fibrillation
Robinson K, McNamara R, Bass E, Powe N. Evidence-based Practice Centers: Production of Evidence Report on Management of Atrial Fibrillation. AACN Advanced Critical Care 2001, 12: 618-627. PMID: 11759433, DOI: 10.1097/00044067-200111000-00018.Peer-Reviewed Original ResearchConceptsEvidence-based Practice CenterEvidence reportPractice centerAtrial fibrillationJohns Hopkins EvidenceEvidence-based careEvidence-based healthcareSpecific clinicSynthesis of evidenceSpecific patientHealthcare ResearchHealthcare practitionersIndividual basisFibrillationEvidence-based productsReportData abstractionPatients
2000
Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.
Miller M, McNamara R, Segal J, Kim N, Robinson K, Goodman S, Powe N, Bass E. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. The Journal Of Family Practice 2000, 49: 1033-46. PMID: 11093570.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnti-Arrhythmia AgentsAtrial FibrillationEvidence-Based MedicineHumansMiddle AgedRandomized Controlled Trials as TopicConceptsAF conversionAtrial fibrillationSinus rhythmOdds ratioModerate evidenceMultiple antiarrhythmic agentsAdverse event ratesClinical trials databasesEfficacy of agentsAdverse event dataPharmacologic conversionAdverse eventsRandomized trialsTrials databasesCochrane CollaborationAntiarrhythmic agentsClinical trialsStudy qualityAgent efficacySuggestive evidenceEvent ratesFlecainideDisopyramideRelative efficacyStrong evidenceManagement of new onset atrial fibrillation.
McNamara R, Bass E, Miller M, Segal J, Goodman S, Kim N, Robinson K, Powe N. Management of new onset atrial fibrillation. Evidence Report Technology Assessment 2000, 1-7. PMID: 11471248, PMCID: PMC4781222.Peer-Reviewed Original ResearchAdultAge DistributionAgedAged, 80 and overAmbulatory CareAnti-Arrhythmia AgentsAnticoagulantsAspirinAtrial FibrillationClinical Trials as TopicComorbidityDecision Support TechniquesEchocardiographyElectric CountershockEvidence-Based MedicineFemaleHumansIncidenceMaleMiddle AgedPrognosisRisk FactorsSex DistributionSurvival RateThromboembolismTreatment OutcomeThe evidence regarding the drugs used for ventricular rate control.
Segal J, McNamara R, Miller M, Kim N, Goodman S, Powe N, Robinson K, Yu D, Bass E. The evidence regarding the drugs used for ventricular rate control. The Journal Of Family Practice 2000, 49: 47-59. PMID: 10678340.Peer-Reviewed Original ResearchConceptsHeart rate controlExercise toleranceAtrial fibrillationHeart rateBetter heart rate controlCochrane Collaboration's CENTRAL databaseCalcium channel blocker verapamilAbstracts of trialsTrial of verapamilImproved exercise toleranceVentricular rate controlTrials of drugsEnglish-language articlesEnglish-language abstractsCentral databaseVentricular rateBlocker verapamilInsufficient evidenceSystematic reviewPlaceboFibrillationTrialsDrugsLanguage publicationsPatients